Amy Burroughs is Chief Executive Officer and Director of Terns Pharmaceuticals, Inc. (TERN). The company reported total compensation of $8,240,502 for fiscal year 2024.
| Salary | $563,701 |
|---|---|
| Bonus | $0 |
| Stock awards | $807,750 |
| Option awards | $6,476,968 |
| Non-equity incentive plan | $375,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $17,083 |
| Total | $8,240,502 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Terns Pharmaceuticals, Inc. filed April 29, 2025, accession 0000950170-25-060138.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Amy Burroughs this page | Chief Executive Officer and Director | $8,240,502 |
| Mark Vignola | Former Chief Financial Officer and Treasurer | $2,916,937 |
| Melita Sun Jung | Chief Business Officer | $2,196,084 |
| Erin Quirk | Former President, Head of Research & Development | $1,934,963 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Terns Pharmaceuticals, Inc. compensation brief.
Amy Burroughs's compensation sits inside Terns Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.